Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Azizi

Showing results (111-120 of 267) with videos related to

Pageof 27
Sort By:
Diagnostic and Interventional Imaging|May 8, 2012
Expert consensus: Renal denervation for the treatment of hypertensionAtul Pathak, Xavier Girerd, Michel Azizi, et al.
American Journal of Hypertension|January 3, 2007
Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartanJames L Pool, Roland E Schmieder, Michel Azizi, et al.
Hypertension (Dallas, Tex. : 1979)|January 10, 2019
Deep Vascular Phenotyping in Patients With Renal Multifocal Fibromuscular DysplasiaRosa Maria Bruno, Louise Marais, Hakim Khettab, et al.
Blood Pressure Monitoring|March 3, 2020
Home blood pressure monitoring and e-Health: investigation of patients' experience with the Hy-Result systemNicolas Postel-Vinay, Olivier Steichen, Emmanuelle Pébelier, et al.
Hypertension (Dallas, Tex. : 1979)|April 15, 2015
Angiotensin II activates the RhoA exchange factor Arhgef1 in humansMaria Luigia Carbone, Jérémy Brégeon, Nabila Devos, et al.
Journal of Hypertension|June 26, 2012
Sequential nephron blockade versus sequential renin-angiotensin system blockade in resistant hypertension: a prospective, randomized, open blinded endpoint studyGuillaume Bobrie, Michael Frank, Michel Azizi, et al.
Blood|June 15, 2006
Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjectsJean-Sébastien Hulot, Alessandra Bura, Eric Villard, et al.
Hypertension (Dallas, Tex. : 1979)|September 19, 2007
Endothelial function and chronic exposure to air pollution in normal male subjectsMarie Briet, Cédric Collin, Stéphane Laurent, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 12, 2018
Usefulness of Magnetic Resonance Imaging in the Diagnosis of Juxtaglomerular Cell Tumors: A Report of 10 Cases and Review of the LiteratureAnne-Laure Faucon, Camille Bourillon, Christine Grataloup, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 5, 2018
Will SPYRAL HTN-ON MED change my practice? SPYRAL HTN-ON MED: a prospective, randomised, sham-controlled trial on renal denervation in the presence of antihypertensive medicationsSebastian Ewen, Lucas Lauder, Michel Azizi, et al.
Pageof 27

Showing results (111-120 of 267) with videos related to

Sort By:
Pageof 27
Diagnostic and Interventional Imaging|May 8, 2012
Expert consensus: Renal denervation for the treatment of hypertensionAtul Pathak, Xavier Girerd, Michel Azizi, et al.
American Journal of Hypertension|January 3, 2007
Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartanJames L Pool, Roland E Schmieder, Michel Azizi, et al.
Hypertension (Dallas, Tex. : 1979)|January 10, 2019
Deep Vascular Phenotyping in Patients With Renal Multifocal Fibromuscular DysplasiaRosa Maria Bruno, Louise Marais, Hakim Khettab, et al.
Blood Pressure Monitoring|March 3, 2020
Home blood pressure monitoring and e-Health: investigation of patients' experience with the Hy-Result systemNicolas Postel-Vinay, Olivier Steichen, Emmanuelle Pébelier, et al.
Hypertension (Dallas, Tex. : 1979)|April 15, 2015
Angiotensin II activates the RhoA exchange factor Arhgef1 in humansMaria Luigia Carbone, Jérémy Brégeon, Nabila Devos, et al.
Journal of Hypertension|June 26, 2012
Sequential nephron blockade versus sequential renin-angiotensin system blockade in resistant hypertension: a prospective, randomized, open blinded endpoint studyGuillaume Bobrie, Michael Frank, Michel Azizi, et al.
Blood|June 15, 2006
Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjectsJean-Sébastien Hulot, Alessandra Bura, Eric Villard, et al.
Hypertension (Dallas, Tex. : 1979)|September 19, 2007
Endothelial function and chronic exposure to air pollution in normal male subjectsMarie Briet, Cédric Collin, Stéphane Laurent, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 12, 2018
Usefulness of Magnetic Resonance Imaging in the Diagnosis of Juxtaglomerular Cell Tumors: A Report of 10 Cases and Review of the LiteratureAnne-Laure Faucon, Camille Bourillon, Christine Grataloup, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 5, 2018
Will SPYRAL HTN-ON MED change my practice? SPYRAL HTN-ON MED: a prospective, randomised, sham-controlled trial on renal denervation in the presence of antihypertensive medicationsSebastian Ewen, Lucas Lauder, Michel Azizi, et al.
Pageof 27